Predictors of response to emergent therapies in paediatric immune thrombocytopenia
British Journal of Haematology · 2025
DOI: 10.1111/bjh.70064 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Candelaria O'Farrell und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Immunoglobulins, Intravenous. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Emergent therapies (ET), which include intravenous immunoglobulin (IVIG), corticosteroids and intravenous anti‐Rho(D) immunoglobulin, are used to treat acute episodes of bleeding in children with immune thrombocytopenia (ITP). There are currently no known biomarkers or clinical features predictive of treatment response to any specific ET. Thus, the treatment of ITP remains largely trial and error, exposing patients to potentially ineffective medications, which are often expensive and associated with adverse effects. We therefore sought to identify the predictors of treatment response through comparison of clinical characteristics in paediatric patients with ITP responsive to ET versus those non‐responsive to ET. We identified high rates of non‐response to ET in our cohort of 511 children diagnosed with ITP over a recent 5‐year period. Through a multivariable logistic regression model, we identified the presence of secondary ITP, the presence of systemic lupus erythematosus, a positive baseline direct antiglobulin test (DAT) and a high baseline IgA level as predictors of non‐response to IVIG. In the future, management guidelines that incorporate predictors of response could help individualize treatment for each patient, achieving better response rates that ensure less bleeding‐related morbidity and avoid unnecessary side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
- Texas Children's Cancer and Hematology Center, Houston, Texas, USA.
- Center for Epidemiology and Population Health, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
ORCID-Profile: Candelaria O'Farrell
Zitieren
APA
O'Farrell, C., Luckie, T. M., Willis, M. J., Kirk, S. E., Lucari, B. R., Scheurer, M. E., Gao, X., & Grimes, A. B. (2025). Predictors of response to emergent therapies in paediatric immune thrombocytopenia. British Journal of Haematology. https://doi.org/10.1111/bjh.70064
Vancouver
O'Farrell C, Luckie TM, Willis MJ, Kirk SE, Lucari BR, Scheurer ME, et al. Predictors of response to emergent therapies in paediatric immune thrombocytopenia. British Journal of Haematology. 2025. doi:10.1111/bjh.70064
BibTeX
@article{OFarrell2025,
author = {O'Farrell, Candelaria and Luckie, Taylor M and Willis, Matthew J and Kirk, Susan E and Lucari, Brandon R and Scheurer, Michael E and Gao, Xiaotian and Grimes, Amanda B},
title = {Predictors of response to emergent therapies in paediatric immune thrombocytopenia},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.70064}
}
EUVIMED